AFP2h
U.S. FDA Grants Full Approval of Deciphera’s ROMVIMZA™ (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor (TGCT)
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZA™ (vimseltinib), a kinase ...
Warning as sweets laced with chemicals linked to cancer 'flood shops'
Several imported fizzy drinks and sweets from America contain banned and illegal ingredients in the UK, according to the ...
Health alert issued over sweets and drinks containing banned substances linked to cancer 'flooding UK'
A number of popular imported fizzy drinks and sweets are said to contain illegal and banned ingredients in the UK, with the ...
Urgent warning issued over sweets and drinks with links to cancer 'flooding UK'
A number of imported fizzy drinks and sweets contain illegal and banned ingredients that can have adverse health effects are ...